ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Achilles Therapeutics PLC

Achilles Therapeutics PLC (ACHL)

1,07
0,02
(1,90%)
Geschlossen 21 November 10:00PM
1,07
0,00
( 0,00% )
Vor Marktöffnung: 10:00AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
1,07
Gebot
1,01
Fragen
1,07
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
1,07
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
41.082.948
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
6,08M
Nettogewinn
-69,67M

Über Achilles Therapeutics PLC

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastati... Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
London, Gbr
Gegründet
-
Achilles Therapeutics PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ACHL. The last closing price for Achilles Therapeutics was US$1,07. Over the last year, Achilles Therapeutics shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Achilles Therapeutics currently has 41.082.948 shares in issue. The market capitalisation of Achilles Therapeutics is US$43,96 million.

ACHL Neueste Nachrichten

Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market

LONDON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced that on November 15, 2024, the Listing Qualifications department of the Nasdaq Stock Market...

Achilles Therapeutics Reports Third Quarter 2024 Financial Results

– Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 –         LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE...

Achilles Therapeutics Announces Strategic Update

–Achilles to discontinue development of TIL-based cNeT therapy– –Cash position of $95.1 million as of June 30, 2024– –BofA Securities engaged to provide strategic financial advice–        ...

Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates

– Announced research collaboration with Arcturus Therapeutics to explore second-generation mRNA cancer vaccines using Achilles’ AI-powered, tumor-targeting technology – – Provided interim Phase...

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines

Combines Achilles’ best-in-class AI-driven, tumor-targeting technology with Arcturus’ world-leading self-amplifying mRNA platform Combined technologies have the potential to generate potent and...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
WORXSCWorx Corporation
US$ 1,85
(88,78%)
14,78M
AKTSAkoustis Technologies Inc
US$ 0,12985
(49,08%)
52,03M
PETWag Group Company
US$ 0,312
(48,50%)
16,27M
CRKNCrown Electrokinetics Corporation
US$ 1,13
(43,83%)
4,35M
ESGROEnstar Group Ltd
US$ 28,00
(40,92%)
24
WSBFWaterstone Financial Inc
US$ 9,00
(-40,98%)
4
TRSTriMas Corporation
US$ 15,62
(-40,79%)
3
BCAXBicara Therapeutics Inc
US$ 11,00
(-40,15%)
208
XNCRXencor Inc
US$ 15,11
(-36,30%)
2
PYXSPyxis Oncology Inc
US$ 2,44
(-36,13%)
201,93k
AKTSAkoustis Technologies Inc
US$ 0,12985
(49,08%)
52,03M
PETWag Group Company
US$ 0,312
(48,50%)
16,27M
WORXSCWorx Corporation
US$ 1,85
(88,78%)
14,78M
XTKGX3 Holdings Company Ltd
US$ 0,0797
(-11,44%)
10,59M
CRKNCrown Electrokinetics Corporation
US$ 1,13
(43,83%)
4,35M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock